Ranibizumab Biosimilar (Razumab) vs Innovator Ranibizumab (Lucentis) in neovascular age-related macular degeneration (n-AMD)- efficacy and safety (BIRA study)

Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Francesco Bandello, Baruch D. Kuppermann, Anat Loewenstein

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalEye
DOIs
StateAccepted/In press - 2021

Cite this